HomePress ReleaseNo Standardized Method of Measuring Patient Engagement Despite 10,000+ People in the...

No Standardized Method of Measuring Patient Engagement Despite 10,000+ People in the Industry

With the FDA now explicitly requiring patient experience data as part of an NDA, it is more important than ever to determine how patient engagement can be quantified in a meaningful way. The implementation of standardized metrics will allow patient engagement teams to demonstrate the impact of their activities consistently and quantifiably on research programs across the breadth of stakeholders.

The Measuring Patient Engagement Summit is the definitive conference for practical answers. This event will act as the honeypot gathering for leading patient engagement experts to share their latest experiences of how they are successfully measuring patient engagement to: inform decision making in improving patient engagement, quantify the impact of patient engagement on recruitment and retention, and ensure the most meaningful outreach to patients and advocacy groups.

Taking place April 9-11, 2024, in Boston, MA, this summit brings together Chief Patient Officers, Patient Engagement leaders and Patient Advocacy experts to establish a roadmap to quantify the success of your patient engagement work, serving as the definitive conference for practical answers “What is the actual ROI for patient engagement? It’s the question that every Patient Engagement Practitioner has to answer every time we create a business case to fund a patient engagement project/campaign/initiative” says Emma Sutcliffe, Vice President & Head of Patient Affairs Global Officer, Ipsen Pharma.

The summit’s program co-created by senior decision makers, promises to be a one-stop-shop for Patient Engagement leaders looking to collectively build a standardized framework to measure the value of patient engagement and ensure that patient engagement remains a key driver for success in drug development. With 70+ industry experts from Novartis, Otsuka, Ipsen Pharma, Travere Therapeutics, Takeda, Boehringer Ingelheim and more, attendees can expect cutting-edge talks, multi-stakeholder panel discussions, and expert-led group discussions.

Don’t miss this opportunity to redefine metrics, optimize strategies and revolutionize patient engagement for a brighter and more impactful healthcare landscape – download the full event guide.

 

Must Read

Related News